These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 19864633)

  • 21. Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration.
    Sperling RE; Gomes SM; Sypek EI; Carey AN; McLaughlin JP
    Psychopharmacology (Berl); 2010 Jun; 210(2):199-209. PubMed ID: 20401606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
    Bruchas MR; Macey TA; Lowe JD; Chavkin C
    J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanism.
    Lemos JC; Roth CA; Messinger DI; Gill HK; Phillips PE; Chavkin C
    J Neurosci; 2012 Sep; 32(36):12325-36. PubMed ID: 22956823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.
    Gross JD; Kaski SW; Schmidt KT; Cogan ES; Boyt KM; Wix K; Schroer AB; McElligott ZA; Siderovski DP; Setola V
    Neuropsychopharmacology; 2019 Sep; 44(10):1728-1741. PubMed ID: 31141817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects.
    Huang P; Chen C; Cao D; Huang M; Liu-Chen LY
    Neuropharmacology; 2022 Jan; 202():108860. PubMed ID: 34736959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
    Liu JJ; Chiu YT; DiMattio KM; Chen C; Huang P; Gentile TA; Muschamp JW; Cowan A; Mann M; Liu-Chen LY
    Neuropsychopharmacology; 2019 Apr; 44(5):939-949. PubMed ID: 30082888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
    Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
    Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice.
    Dunn A; Windisch K; Ben-Ezra A; Pikus P; Morochnik M; Erazo J; Reed B; Kreek MJ
    Psychopharmacology (Berl); 2020 Aug; 237(8):2405-2418. PubMed ID: 32435819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation.
    Conway SM; Puttick D; Russell S; Potter D; Roitman MF; Chartoff EH
    Neuropharmacology; 2019 Mar; 146():231-241. PubMed ID: 30528327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner.
    Tejeda HA; Natividad LA; Orfila JE; Torres OV; O'Dell LE
    Psychopharmacology (Berl); 2012 Nov; 224(2):289-301. PubMed ID: 22659976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine.
    Ward M; Norman H; D'Souza MS
    Behav Brain Res; 2018 Feb; 338():56-65. PubMed ID: 29037662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system.
    Redila VA; Chavkin C
    Psychopharmacology (Berl); 2008 Sep; 200(1):59-70. PubMed ID: 18575850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single, extinction-based treatment with a kappa opioid receptor agonist elicits a long-term reduction in cocaine relapse.
    Heinsbroek JA; Furbish AB; Peters J
    Neuropsychopharmacology; 2018 Jun; 43(7):1492-1497. PubMed ID: 29472645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.
    Bruchas MR; Land BB; Lemos JC; Chavkin C
    PLoS One; 2009 Dec; 4(12):e8528. PubMed ID: 20052275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the Alpha-1 Antagonist Prazosin on KOR Agonist-Induced Reinstatement of Alcohol Seeking.
    Funk D; Coen K; Tamadon S; Lê AD
    Int J Neuropsychopharmacol; 2019 Nov; 22(11):724-734. PubMed ID: 31556948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory.
    Carey AN; Lyons AM; Shay CF; Dunton O; McLaughlin JP
    J Neurosci; 2009 Apr; 29(13):4293-300. PubMed ID: 19339623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice.
    Anderson RI; Lopez MF; Griffin WC; Haun HL; Bloodgood DW; Pati D; Boyt KM; Kash TL; Becker HC
    Neuropsychopharmacology; 2019 May; 44(6):1084-1092. PubMed ID: 30555162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference.
    Smith JS; Schindler AG; Martinelli E; Gustin RM; Bruchas MR; Chavkin C
    J Neurosci; 2012 Jan; 32(4):1488-95. PubMed ID: 22279233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.
    Eans SO; Ganno ML; Reilley KJ; Patkar KA; Senadheera SN; Aldrich JV; McLaughlin JP
    Br J Pharmacol; 2013 May; 169(2):426-36. PubMed ID: 23425081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.